New 26-Valent pneumonia vaccine shows promise in early trials
NCT ID NCT06703203
First seen Apr 05, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested a new vaccine that protects against 26 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. About 450 people aged 2 months and older received the vaccine to check its safety and how well it triggers the immune system. The trial is complete, and results will help decide if the vaccine should move to larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMOCOCCAL VACCINES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henan Provincial Center for Disease Control and Prevention
Shangqiu, Henan, 476700, China
Conditions
Explore the condition pages connected to this study.